Craneware plc

AIM-CRW
London Stock Exchange AIM
Healthcare Medical - Healthcare Information Services
Global Rank
#9255
Country Rank
#257
Market Cap
1.07 B
Price
3,058.05
Change (%)
1.82%
Volume
20,068

Craneware plc's latest marketcap:

1.07 B

As of 07/06/2025, Craneware plc's market capitalization has reached $1.07 B. According to our data, Craneware plc is the 9255th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.07 B
Revenue (ttm) 216.02 M
Net Income (ttm) 16.22 M
Shares Out 35.02 M
EPS (ttm) 0.46
Forward PE 29.54
Ex-Dividend Date 03/20/2025
Earnings Date 06/09/2025
Market Cap Chart
Data Updated: 07/06/2025

Craneware plc's yearly market capitalization.

Craneware plc has seen its market value grow from £127.72 M to £1.07 B since 2014, representing a total increase of 738.50% and an annual compound growth rate (CAGR) of 22.41%.
Date Market Cap Change (%) Global Rank
07/06/2025 £1.07 B 4.27% 9255
12/31/2024 £738.88 M 20.69% 9223
12/29/2023 £612.23 M -3.93% 10106
12/30/2022 £637.29 M -26.03% 9670
12/31/2021 £861.52 M 41.56% 8537
12/31/2020 £608.59 M -10.9% 8841
12/31/2019 £683.01 M 4.42% 7243
12/31/2018 £654.13 M 67.11% 6803
12/29/2017 £391.43 M 9.57% 10152
12/30/2016 £357.24 M 66.93% 9890

Company Profile

About Craneware plc

Craneware plc, along with its subsidiaries, specializes in developing, licensing, and supporting computer software tailored for the healthcare industry in the United States.

Key Solutions

  • Trisus Pricing Transparency Software: Simplifies and automates the price modeling process.
  • Trisus Chargemaster: An automated chargemaster management solution.
  • InSight Medical Necessity: Provides medical necessity requirements.
  • Trisus Claims Informatics: A retrospective charge capture analytical application.
  • Trisus Supply: Enhances supplies reimbursement.
  • InSight Audit: An audit solution for government and commercial payors.

Additional Offerings

  • Trisus Decision Support: Aids in strategic decision-making.
  • Trisus Labor Productivity: Manages workforce deployment and analysis.
  • Trisus Medication Analytic Solutions: Resolves medication system issues.
  • Sentrex: SaaS-based solution for expanding medication access.
  • Sentinel: Tracks all drug activity.
  • Referral Verification System: Ensures accurate referrals.

Professional Services

The company also provides professional, pharmacy professional, and appeal services, along with The Academy, an interactive learning center for user training.

Suite Solutions

  • Trisus Pricing Integrity Suite
  • Trisus Business of Pharmacy Suite
  • Trisus Value-based Margin and Productivity Suite
  • Trisus Data Integrity Suite

Founded: 1999
Headquarters: Edinburgh, United Kingdom

Frequently Asked Questions

  • What is Craneware plc's (AIM-CRW) current market cap?
    As of 07/06/2025, Craneware plc (including the parent company, if applicable) has an estimated market capitalization of $1.07 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Craneware plc global market capitalization ranking is approximately 9255 as of 07/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.